(Reuters) -Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human ...

Robi, 30, was vaccinated with Gardasil as a teenager and claims the shot led to impaired mobility that confined her to a ...

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant currency revenue growth and delivered ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused about its prospects in 2025.

Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, the company delivers health solutions through its prescription ...

Merck's stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years, after the drug company's softer-than-expected guidance amid struggles for its HPV vaccine ...

For 2025 Merck, based in Rahway, New Jersey, expects adjusted earnings to range between $8.88 and $9.03 per share on $64.1 billion to $65.6 billion in sales. Analysts had been projecting earnings ...

Shares of Merck slid Tuesday after the drugmaker surprised ... earnings of $9.13 per share on $67.07 billion in sales for the Rahway, New Jersey, company. For the recently completed fourth quarter ...

Merck swung to a quarterly profit as sales grew ... Gardasil, hit shares. The Rahway, N.J., company Tuesday reported fourth-quarter net income of $3.74 billion, or $1.48 a share, compared with ...